Jeremy J. Flood, MD
Diabetes, Endocrinology
Accepting new patients
Sees patients age 18 and up
Penn Endocrinology and Diabetes University City
Schedule onlineCall 215-662-9905
Penn Medicine Provider

About me

  • Chief, Division of Endocrinology, Penn Presbyterian Medical Center
  • Professor of Clinical Medicine (Endocrinology, Diabetes and Metabolism)

Education and training

  • Medical School: State University of New York at Buffalo
  • Residency: Thomas Jefferson University Hospital
  • Fellowship: Thomas Jefferson University Hospital

What my patients think about me

Average Rating

333 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

October 2025
great doctor
October 2025
always been good
October 2025
very caring and thorough.
October 2025
compassionate and very intelligent always looks out for me

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. Flood is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

My research

Hvisdas CM, Goode ND, Kim DH, Silvey MJ, Flood JJ Characterization of Interchanging Incretin Analogs in Clinical Practice: A Descriptive Report , Endocrine Practice: 2024

Passman J, Hwang J MD MS, Tang J, Epps M, Chambers C, Cook T, Fagan M, Peifer M, Flood J, Delgado K, Fraker DL, Wachtel H, Kelz RR, Herman DS. Development of Comprehensive Decision Support to Improve Screening for Primary Hyperparathyroidism. , Oral podium presentation at Nudges in Health Care Symposium in Philadelphia, PA.: 2024

Hwang J, Passman J, Tang T, Fagen M, Epps M, Chambers C, Cook T, Peifer M, Flood J, Delgado K, Fraker DL, Wachtel H, Herman DS, Kelz RR. Electronic Medical Record-Based Behavioral Nudges to Improve Screening Rates for Primary Hyperparathyroidism. , Oral podium and poster presentation. Presented at American College of Surgeons Quality and Safety Conference in Denver, CO.: 2024

Jesse M. Raiten, Andrea Morlok, Sarah D'Ambrosia, Michael A. Ruggero, Jeremy Flood Perioperative Management of Patients Receiving Sodium Glucose Co-Transporter-2 Inhibitors: Development of a Clinical Guideline at a Large Academic Medical Center , Journal of Cardiothoracic and Vascular Anesthesia: 2023

Passman J, Hwang J, Fagen M, Epps M, Peifer M, Flood J, Nicklin D, Delgado MK, Kelz R, Herman D Electronic health record-based nudges to enhance screening rates for primary hyperparathyroidism: a pilot study , Nudges in Health Care Symposium: 2023

Jo Kamimoto, Jorge L.; Flood, Jeremy J. Systemic Thyroid Dysfunction in Graves Disease , International Ophthalmology Clinics, 63(2): 2023,55-63

L McLeer Maloney, J Flood, N Alamuddin, M Al Mukaddam Findings from a Diabetes Support Group—A Pilot Study , Diabetes, 67(Supplement 1): 2018,720

Simon B, Flood J, Jabbour S Type 1 Diabetes in Adults , Oxford American Endocrinology Library : 2011

Flood JJ, Miller JL. Treatment of Type 2 Diabetes Mellitus with Oral Agents , A Case-based Guide to Clinical Endocrinology: 2008,359-365

Ahmed I, Furlong K, Flood J, Treat VP, Goldstein BJ. Dual PPAR alpha/gamma Agonists: Promises and Pitfalls in Type 2 Diabetes , American Journal of Therapeutics, 14: 2007,49-62